Andrew Lo
Director at BridgeBio Pharma; Director at Roivant Sciences. Based in Palo Alto, California.
- Rank
- 10958th of 14,644
- Companies held
- 2
- Largest holding
- BBIO, 72.5% of total
- Latest SEC filing
- Jun 22, 2026
What the $7.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| BridgeBio Pharma BBIO Common Stock | Through Andrew W. Lo and Nancy N. Lo JTWROS | 50,583 | $78.18 | $4.0M | 53.4% | Form 4, Jun 22, 2026 |
| Roivant Sciences ROIV Common Shares | Directly | 52,142 | $38.96 | $2.0M | 27.5% | Form 4, Sep 15, 2022 |
| BridgeBio Pharma BBIO Common Stock | Directly | 18,079 | $78.18 | $1.4M | 19.1% | Form 4, Jun 22, 2026 |
Share counts are the amounts Andrew Lo reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 10955 | Gordon Nixon Director, BlackRock. New York, NY | $7.4M |
| 10956 | John A. Graf Director, Everest Group. Houston, TX | $7.4M |
| 10957 | Jennifer L. Klobnak CHIEF OPERATING OFFICER, RLI. Peoria, IL | $7.4M |
| 10958 | Andrew Lo Director, BridgeBio Pharma. Palo Alto, CA | $7.4M |
| 10959 | Linda P. Jojo EVP & Chief Customer Officer, United Airlines Holdings. Chesterfield, MO | $7.4M |
| 10960 | Thomas J.W. Dittrich EVP & CFO, Amgen. Thousand Oaks, CA | $7.4M |
| 10961 | Anna Marrs Group Pres., GMNS, American Express. New York, NY | $7.4M |
Other BridgeBio Pharma insiders
All BBIO insiders- Neil Kumar$438MChief Executive Officer. #525 overall
- Charles J. Homcy$71.9MDirector. #1925 overall
- Frank McCormick$60.0MDirector. #2240 overall
- Thomas Trimarchi$24.5MPresident and CFO. #4437 overall
- Ali J. Satvat$13.3MDirector. #7083 overall
- Maricel Apuli$9.1MChief Accounting Officer. #9442 overall
Questions
How much stock does Andrew Lo own?
Andrew Lo holds $7,399,447 in listed stock based on SEC filings and current prices, mostly BridgeBio Pharma (BBIO). That ranks 10958th on the Stock Rich List.
Is this Andrew Lo's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Andrew Lo last buy or sell stock?
The most recent open-market trade on file is a sale of 30,993 BBIO shares on Nov 18, 2025 at $66.05.